JPS59133201A - 多糖類の解重合およびスルフエ−ト化法 - Google Patents

多糖類の解重合およびスルフエ−ト化法

Info

Publication number
JPS59133201A
JPS59133201A JP58252447A JP25244783A JPS59133201A JP S59133201 A JPS59133201 A JP S59133201A JP 58252447 A JP58252447 A JP 58252447A JP 25244783 A JP25244783 A JP 25244783A JP S59133201 A JPS59133201 A JP S59133201A
Authority
JP
Japan
Prior art keywords
heparin
depolymerized
acid
sulfate
starting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58252447A
Other languages
English (en)
Japanese (ja)
Inventor
アンナマリア・ナギ−
ジヤン・ジヤアコモ・トリ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Anic SpA
Original Assignee
Sanofi SA
Anic SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9280592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS59133201(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi SA, Anic SpA filed Critical Sanofi SA
Publication of JPS59133201A publication Critical patent/JPS59133201A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
JP58252447A 1982-12-28 1983-12-28 多糖類の解重合およびスルフエ−ト化法 Pending JPS59133201A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8221934A FR2538404B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-12-28 1982-12-28
FR8221934 1982-12-28
FR8319506 1983-12-06

Publications (1)

Publication Number Publication Date
JPS59133201A true JPS59133201A (ja) 1984-07-31

Family

ID=9280592

Family Applications (2)

Application Number Title Priority Date Filing Date
JP58252447A Pending JPS59133201A (ja) 1982-12-28 1983-12-28 多糖類の解重合およびスルフエ−ト化法
JP58252446A Expired - Lifetime JPH0629282B2 (ja) 1982-12-28 1983-12-28 解重合及び超硫酸化ヘパリン、その製造方法並びに製薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP58252446A Expired - Lifetime JPH0629282B2 (ja) 1982-12-28 1983-12-28 解重合及び超硫酸化ヘパリン、その製造方法並びに製薬組成物

Country Status (14)

Country Link
US (1) US4727063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0116801B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JPS59133201A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR910008329B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE26281T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU563289B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1210760A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3370632D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK597983A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2538404B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE56566B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL70512A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ206697A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (2) ZA839651B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203602A (ja) * 1983-12-06 1985-10-15 サノフイ キトサン６−スルフエ−トおよびその製法
JP2005344073A (ja) * 2004-06-07 2005-12-15 Maruho Co Ltd 多硫酸化コンドロイチン硫酸の製造方法
JP2006077227A (ja) * 2004-09-13 2006-03-23 Lab Derivati Organici Spa コンドロイチンの硫酸化方法
JP2014513742A (ja) * 2011-05-20 2014-06-05 グノーシス・エツセ・ピー・アー サメに類似するコンドロイチン硫酸およびこの調製のための方法
JP2019501263A (ja) * 2015-12-30 2019-01-17 シェンツェン ヘパリンク ファーマスーティカル グループ カンパニー リミテッドＳｈｅｎｚｈｅｎ Ｈｅｐａｌｉｎｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． 硫酸化ヘパリン由来オリゴ糖及びその調製法と施用

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948881A (en) * 1982-12-28 1990-08-14 Sanofi Process for the depolymerization and sulfation of polysaccharides
IT1163772B (it) * 1983-07-13 1987-04-08 Baldacci Lab Spa Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US5262403A (en) * 1986-03-10 1993-11-16 Board Of Regents, The University Of Texas System Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
US5145841A (en) * 1987-03-19 1992-09-08 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
AU3434889A (en) * 1988-03-15 1989-10-05 Jewish Hospital Of St. Louis, The Inhibition of intestinal cholesterol and fatty acid absorption
US4945086A (en) * 1988-05-03 1990-07-31 The Board Of Trustees Of The Leland Stanford Junior University Smooth muscle cell growth inhibitor
JPH04500377A (ja) * 1988-06-03 1992-01-23 イタルファルマコ　エッセ　ピ　ア グリコサミノグリカン塩、その製造方法およびそれを含有する医薬組成物
US5017565A (en) * 1989-04-20 1991-05-21 Lange Iii Louis G Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5484777A (en) * 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
ES2062307T3 (es) * 1989-10-04 1994-12-16 Akzo Nv Un proceso para la fabricacion de glicosaminoglicuronano sulfatado con actividad antitrombotica.
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides
IT1243987B (it) * 1990-10-29 1994-06-28 Derivati Organici Lab Procedimento per la preparazione di epossi-eparidi prodotti ottenuti ecomposizioni farmaceutiche che li contengono
FR2669932B1 (fr) * 1990-12-03 1994-07-01 Sanofi Sa Nouvel heparosane-n,o-sulfate, son procede de preparation et les compositions pharmaceutiques qui le contiennent.
IT1244373B (it) * 1991-01-18 1994-07-08 Sclavo Spa Composizioni farmaceutiche per uso orale contenenti eparina a basso peso molecolare, loro preparazione ed uso
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
US5861382A (en) * 1992-05-01 1999-01-19 Yeda Research And Development Co. Ltd. Methods for regulation of active TNF-α
PL309001A1 (en) * 1992-11-10 1995-09-18 Yeda Res & Dev Compositions for controlling activity of cytokinins
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
WO1995033468A1 (en) * 1994-06-06 1995-12-14 Oestergaard Per Bjoern A pharmaceutical composition comprising oligosaccharides binding to lipoprotein lipase
AU682792B2 (en) 1994-10-13 1997-10-16 Cv Therapeutics, Inc. Method of manufacturing non-absorbable synthetic sulfated polysaccharides
US5922690A (en) * 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation
EP1039883A4 (en) 1996-07-09 2001-09-26 Keith A Crutcher METHOD FOR TREATING APOLIPOPROTEIN E CONDITIONAL DISEASES
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
US6388060B1 (en) 1998-11-06 2002-05-14 Vascular Therapeutics Inc. Process for the sulfation of uronic acid-containing polysaccharides
DE29900874U1 (de) 1999-01-20 1999-07-22 Knoll AG, 67061 Ludwigshafen Organprotektive Lösungen
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
HK1045532A1 (zh) * 1999-06-30 2002-11-29 Hamilton Civic Hospitals Research Development, Inc. 抑制与凝结有关凝结因子的肝素成份
US8227449B2 (en) 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
FR2807918B1 (fr) 2000-04-21 2003-07-04 Equip Tech Ind Alimentaires Retourneur avec galets mobiles sur surfaces de guidage
BR0113886A (pt) * 2000-09-08 2003-07-15 Hamilton Civic Hospitals Res Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit
US20050119469A1 (en) * 2001-08-31 2005-06-02 Smith Gregory A. Saccharide sulfation methods
US7285536B2 (en) * 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
DE602005026293D1 (de) * 2004-07-19 2011-03-24 Onconova Therapeutics Inc Formulierungen für die parenterale verabreichung von (e)-2,6-dialkoxystryryl 4-substituierten benzylsulfonen
NZ565561A (en) * 2005-07-29 2011-01-28 Onconova Therapeutics Inc Formulation of radioprotective alpha, beta unsaturated aryl sulfones
EP2046343B1 (en) * 2006-07-28 2014-05-14 Onconova Therapeutics, Inc. Formulations of radioprotective alpha, beta unsaturated aryl sulfones
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
ES2567079T3 (es) * 2007-11-02 2016-04-19 Momenta Pharmaceuticals, Inc. Composiciones de polisacáridos que no son anticoagulantes
US8569262B2 (en) * 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
RU2408379C2 (ru) * 2009-03-04 2011-01-10 Учреждение Российской Академии Наук Институт Нефтехимии И Катализа Ран Антикоагулянтное средство с противовоспалительной и противоопухолевой активностью
CN101597343B (zh) * 2009-05-07 2011-06-15 张丽萍 一种低分子肝素的基团修饰方法
US9387256B2 (en) 2010-04-16 2016-07-12 Momenta Pharmaceuticals, Inc. Tissue targeting
JP5905455B2 (ja) 2010-06-17 2016-04-20 モメンタ ファーマシューティカルズ インコーポレイテッド 発毛を促進する方法および組成物
US10016449B2 (en) 2013-05-28 2018-07-10 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions
CN103833869B (zh) * 2014-02-26 2016-01-20 上海中医药大学 一种木香硫酸化多糖及其制备方法和用途
EP3677587A4 (en) 2016-08-31 2021-04-14 Oji Holdings Corporation XYLOOLIGOSACCHARIDE ACID, AND METHOD FOR MANUFACTURING THE SAME
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
MX390883B (es) 2017-05-31 2025-03-21 Oji Holdings Corp Preparacion hidratante topica
US11390693B2 (en) 2017-09-12 2022-07-19 Oji Holdings Corporation Pentosan polysulfate and method for producing pentosan polysulfate
SG11202005749WA (en) 2017-12-20 2020-07-29 Oji Holdings Corp Pentosan polysulfate and medicine containing pentosan polysulfate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56803A (en) * 1979-06-18 1981-01-07 Mitsubishi Chem Ind Ltd Preparation of vegetable polysaccharide sulfate ester

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE498062A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) *
US2599172A (en) * 1948-11-29 1952-06-03 Searle & Co Sulfuric acid esters of hyaluronic acid and processes for the production thereof
CH277483A (de) * 1949-10-20 1951-08-31 Hoffmann La Roche Verfahren zur Herstellung eines hochaktiven blutgerinnungshemmenden Mittels.
US2697093A (en) * 1949-12-16 1954-12-14 Phillips Petroleum Co Process for production of alkali metal polysaccharide sulfates
US2755275A (en) * 1952-08-29 1956-07-17 Abbott Lab Process for sulfating chitin
ES343957A1 (es) * 1967-08-09 1968-10-01 Rocador Sa Procedimiento de obtencion de polisacaridos sulfatados an- tilipemicos activos por via oral.
JPS5027884A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-07-12 1975-03-22
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
SE7811306L (sv) * 1978-11-01 1980-05-02 Rothman Gunnvor Antikoagulationsmedel samt sett for dess framstellning
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
US4281168A (en) * 1979-04-02 1981-07-28 The Upjohn Company 11-Deoxy-inter-oxa-19-oxo-PGE1 compounds
US4266077A (en) * 1979-12-26 1981-05-05 American Cyanamid Company Naphthalenetetrayltetrakis(sulfonylimino)-aryl multicarboxylic acids and salts thereof
JPS56120704A (en) * 1980-01-28 1981-09-22 Hepar Ind Inc Method of obtaining low molecular weight heparin having heightened pharmacologic property* product manufactured thereby and its use
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
IL70511A (en) 1982-12-28 1990-01-18 Anic Spa Process for the concurrent depolymerization and sulfation of polysaccharides at hydroxyl groups

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56803A (en) * 1979-06-18 1981-01-07 Mitsubishi Chem Ind Ltd Preparation of vegetable polysaccharide sulfate ester

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203602A (ja) * 1983-12-06 1985-10-15 サノフイ キトサン６−スルフエ−トおよびその製法
JP2005344073A (ja) * 2004-06-07 2005-12-15 Maruho Co Ltd 多硫酸化コンドロイチン硫酸の製造方法
JP2006077227A (ja) * 2004-09-13 2006-03-23 Lab Derivati Organici Spa コンドロイチンの硫酸化方法
JP2014513742A (ja) * 2011-05-20 2014-06-05 グノーシス・エツセ・ピー・アー サメに類似するコンドロイチン硫酸およびこの調製のための方法
JP2019501263A (ja) * 2015-12-30 2019-01-17 シェンツェン ヘパリンク ファーマスーティカル グループ カンパニー リミテッドＳｈｅｎｚｈｅｎ Ｈｅｐａｌｉｎｋ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． 硫酸化ヘパリン由来オリゴ糖及びその調製法と施用

Also Published As

Publication number Publication date
US4727063A (en) 1988-02-23
JPH0629282B2 (ja) 1994-04-20
CA1210760A (en) 1986-09-02
ZA839651B (en) 1985-02-27
DK597983A (da) 1984-06-29
EP0116801A1 (fr) 1984-08-29
IE833062L (en) 1984-06-28
ATE26281T1 (de) 1987-04-15
DK597983D0 (da) 1983-12-23
ZA839652B (en) 1984-08-29
EP0116801B1 (fr) 1987-04-01
IL70512A (en) 1989-08-15
NZ206697A (en) 1986-10-08
KR840006812A (ko) 1984-12-03
DE3370632D1 (en) 1987-05-07
FR2538404B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-08-23
IL70512A0 (en) 1984-03-30
AU2285583A (en) 1984-07-05
IE56566B1 (en) 1991-09-11
JPS59133202A (ja) 1984-07-31
AU563289B2 (en) 1987-07-02
KR910008329B1 (ko) 1991-10-12
FR2538404A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-06-29

Similar Documents

Publication Publication Date Title
JPS59133201A (ja) 多糖類の解重合およびスルフエ−ト化法
US4948881A (en) Process for the depolymerization and sulfation of polysaccharides
Vikhoreva et al. Preparation and anticoagulant activity of a low-molecular-weight sulfated chitosan
US4814437A (en) Method for preparation of sulfated polysaccharides by treating the polysaccharide with a reducing agent before sulfation
US4990502A (en) Low molecular weight heparins of regular structure, their preparation and their biological uses.
DK160764B (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive heparinfragmenter
AU639427B2 (en) Novel dermatan sulfate and heparin oligosaccharides having antiatherosclerotic activity
JP2001505940A (ja) 抗増殖活性を有する新規な酪酸エステルおよびこれを含む薬剤組成物
RU2670767C9 (ru) Способ получения низкомолекулярного гепарина
KR920003692B1 (ko) 다당류의 해중합 및 황산염화 방법
JP2001518133A (ja) 高い抗血栓症活性を有するグリコサミノグリカン類
JP4394950B2 (ja) 遊離ヒドロキシル（ｏｈ）基または第一級または第二級アミンを含有する化合物をスルホン化する方法
CA2293587A1 (en) Oligosaccharide mixtures having antithrombotic activity
JPH0643446B2 (ja) キトサン６−スルフエ−トおよびその製法
JPH04117401A (ja) スルフォン化キトサンの製造法
AU2002327578B2 (en) Saccharide sulfation methods
CN115210266B (zh) 多糖在生态可接受溶剂中直接硫酸化的方法
CN110256590A (zh) 一种木聚糖硫酸酯的制备方法
SU981322A1 (ru) Способ получени водорастворимого линейного полисахарида
Teshirogi et al. Preparation of sulfated aminodeoxycelluloses
JP7419805B2 (ja) 硫酸化アルギン酸類遷移金属塩
JPH06211903A (ja) 硫酸化キトサンの製造方法およびキトサンの硫酸化剤
JPH03185001A (ja) ヘパリンのｎ―アセチル化物及びその製造方法
JPS609043B2 (ja) 脱硫酸化ムコ多糖体の製造法
RU2048475C1 (ru) Способ получения сульфатированного хитозана